• Focused on improving patient care

  • Quality matters
    Plasmasicherheit

  • Understanding the fragility and value of life

  • Developing future solutions for unmet patient needs


News

22.01.2018
Low inhibitor rate with octanate® in previously untreated patients (PUPs) with severe haemophilia A

Lachen, Switzerland, January 22nd, 2018: Octapharma is delighted to announce the publication of fina...

21.11.2017
Octapharma donates 30.5 million international units of its medicine Nuwiq® to treat people with haemophilia in developing countries

Lachen, Switzerland, November 21st, 2017: Octapharma is pleased to announce the completion of a char...